← back to search

Konrad Grützmann

Zimmer Biomet (Netherlands) · NL
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Extracellular vesicles in disease, Brain Metastases and Treatment, and Cancer Cells and Metastasis.
h-index
18
citations
1,421
works
52
NIH funding
primary concept
email

Recent publications

Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles
Biology Direct 2024cited by 15position: firstdoi
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Nature Communications 2023cited by 46position: middledoi
Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma
Journal of Hematology & Oncology 2023cited by 29position: middledoi
Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases
Journal of Investigative Dermatology 2023cited by 24position: middledoi
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
EMBO Molecular Medicine 2022cited by 68position: middledoi
Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model
International Journal of Molecular Sciences 2022cited by 9position: middledoi
Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 3position: middledoi
Patient-Derived Organoids of Cholangiocarcinoma
International Journal of Molecular Sciences 2021cited by 57position: middledoi
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation
Circulation Research 2021cited by 40position: middledoi
The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib
Gynecologic Oncology 2020cited by 5position: middledoi
Human gastric cancer modelling using organoids
Gut 2018cited by 316position: middledoi
MEST mediates the impact of prenatal bisphenol A exposure on long-term body weight development
Clinical Epigenetics 2018cited by 94position: middledoi
Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia
Nature Communications 2018cited by 70position: middledoi
Hypoxia-induced epigenetic silencing of polo-like kinase 2 promotes fibrosis in atrial fibrillation
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 1position: middledoi
Die Wirkung des konjugierten Antimetabolit-Wirkstoffes 5-FdU-ECyd auf platinresistente Ovarialkarzinomzellen in vitro
Geburtshilfe und Frauenheilkunde 2018cited by 0position: middledoi
Maternal phthalate exposure promotes allergic airway inflammation over 2 generations through epigenetic modifications
Journal of Allergy and Clinical Immunology 2017cited by 118position: middledoi
Early-onset childhood atopic dermatitis is related to NLRP2 repression
Journal of Allergy and Clinical Immunology 2017cited by 27position: middledoi
The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells<i>in vitro</i>
Oncotarget 2017cited by 8position: middledoi
Environment‐induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children
Molecular Systems Biology 2016cited by 109position: middledoi
Alternative splicing of mutually exclusive exons—A review
Biosystems 2013cited by 83position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Barbara Klink · University of Luxembourg6 papers (2017–2023)Evelin Schröck · German Cancer Research Center4 papers (2017–2024)Pauline Wimberger · Kliniken Essen-Mitte4 papers (2017–2020)Daniela E. Aust · Helmholtz-Zentrum Dresden-Rossendorf4 papers (2018–2024)Doreen William · Max Planck Institute of Molecular Cell Biology and Genetics4 papers (2021–2024) · 3 papers (2017–2018) · 3 papers (2017–2018)Roland Eils · University of Michigan3 papers (2017–2018)Michael Borte · Klinikum St. Georg3 papers (2017–2018)Loreen Thürmann · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2017–2018) · 3 papers (2017–2018)Irina Lehmann · Fudan University3 papers (2017–2018)Gustavo Baretton · National Center for Tumor Diseases3 papers (2018–2024)Martin von Bergen� · Helmholtz Centre for Environmental Research3 papers (2017–2018)Jan Dominik Kuhlmann · German Cancer Research Center3 papers (2017–2020)Alexander Krüger · Helmholtz-Zentrum Dresden-Rossendorf3 papers (2020–2024)Tobias Bauer · German Cancer Research Center3 papers (2017–2018)Jürgen Weitz · University Medical Center Hamburg-Eppendorf3 papers (2018–2023)Saskia Trump · German Center for Lung Research3 papers (2017–2018)Melanie Bewerunge‐Hudler · German Cancer Research Center2 papers (2017–2018)